BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29209141)

  • 21. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
    Park J; Lee EH; Sim H; Na AY; Choi SY; Chung JW; Ha YS; Kwon TG; Lee S; Lee JN
    Cancer Genomics Proteomics; 2023; 20(6):592-601. PubMed ID: 37889066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma.
    Deng W; Xie Z; Chen L; Li W; Li M
    Aging (Albany NY); 2024 Jan; 16(2):1249-1275. PubMed ID: 38271056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma.
    Liu S
    Eur J Med Res; 2024 Jan; 29(1):70. PubMed ID: 38245763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
    Li F; Yang M; Li Y; Zhang M; Wang W; Yuan D; Tang D
    BMC Bioinformatics; 2020 Jun; 21(1):232. PubMed ID: 32513106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma.
    Cheng X; Hou Y
    Front Oncol; 2023; 13():1280618. PubMed ID: 37927470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel method to identify pathways associated with renal cell carcinoma based on a gene co-expression network.
    Ruan X; Li H; Liu B; Chen J; Zhang S; Sun Z; Liu S; Sun F; Liu Q
    Oncol Rep; 2015 Aug; 34(2):567-76. PubMed ID: 26058425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of crucial genes through WGCNA in the progression of gastric cancer.
    Liu R; Liu J; Cao Q; Chu Y; Chi H; Zhang J; Fu J; Zhang T; Fan L; Liang C; Luo X; Yang X; Li B
    J Cancer; 2024; 15(11):3284-3296. PubMed ID: 38817876
    [No Abstract]   [Full Text] [Related]  

  • 28. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression.
    Hu J; Wang SG; Hou Y; Chen Z; Liu L; Li R; Li N; Zhou L; Yang Y; Wang L; Wang L; Yang X; Lei Y; Deng C; Li Y; Deng Z; Ding Y; Kuang Y; Yao Z; Xun Y; Li F; Li H; Hu J; Liu Z; Wang T; Hao Y; Jiao X; Guan W; Tao Z; Ren S; Chen K
    Nat Genet; 2024 Mar; 56(3):442-457. PubMed ID: 38361033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treg-Related Genes Representing a Potential Shared Biological Mechanism Between Clear Cell Renal Carcinoma and Obesity.
    Zhou X; Li P; Xu Q; Ye J
    J Coll Physicians Surg Pak; 2024 Feb; 34(2):193-201. PubMed ID: 38342871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of m
    Li H; Li C; Zhang Y; Jiang W; Zhang F; Tang X; Sun G; Xu S; Dong X; Shou J; Yang Y; Chen M
    Mol Carcinog; 2024 Apr; 63(4):677-687. PubMed ID: 38362848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma.
    Gao Q; Ye X; Li F
    Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ProNetView-ccRCC: A Web-Based Portal to Interactively Explore Clear Cell Renal Cell Carcinoma Proteogenomics Networks.
    Kalayci S; Petralia F; Wang P; Gümüş ZH
    Proteomics; 2020 Nov; 20(21-22):e2000043. PubMed ID: 32358997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.
    Li HJ; Li WX; Dai SX; Guo YC; Zheng JJ; Liu JQ; Wang Q; Chen BW; Li GH; Huang JF
    Oncol Lett; 2018 Feb; 15(2):2316-2322. PubMed ID: 29434939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.
    Wu D; Xu Z; Shi Z; Li P; Lv H; Huang J; Fu D
    Comput Math Methods Med; 2022; 2022():4456987. PubMed ID: 36081434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Multi-omic Profiling of Clear Cell Renal Cell Carcinoma Identifies Metabolic Reprogramming Associated with Disease Progression.
    Jiang A; Qu L; Cai C; Luo P; Wang L
    Eur Urol; 2024 Jul; 86(1):76-77. PubMed ID: 38614822
    [No Abstract]   [Full Text] [Related]  

  • 36. Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
    Revel M; Rezola Artero M; Hamidi H; Grunenwald A; Blasco L; Vano YA; Marie Oudard S; Sanchez-Salas R; Macek P; Rodriguez Sanchez L; Cathelineau X; Vedié B; Sautes-Fridman C; Herman Fridman W; Roumenina LT; Dragon-Durey MA
    Oncoimmunology; 2024; 13(1):2328433. PubMed ID: 38487624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma.
    Zamora-Fuentes JM; Hernández-Lemus E; Espinal-Enríquez J
    Front Genet; 2020; 11():578679. PubMed ID: 33240325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression Network Analysis Reveals Key Genes Related to Ankylosing spondylitis Arthritis Disease: Computational and Experimental Validation.
    Najafzadeh L; Mahmoudi M; Ebadi M; Dehghan Shasaltaneh M
    Iran J Biotechnol; 2021 Jan; 19(1):e2630. PubMed ID: 34179194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma.
    Aydin B; Arga KY
    Front Endocrinol (Lausanne); 2019; 10():361. PubMed ID: 31244774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skipping of
    Feldner AC; Turner AK; Simpson JF; Estus S
    J Alzheimers Dis Rep; 2023; 7(1):1313-1322. PubMed ID: 38143775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.